Primary bilateral uveal melanoma: a population-based study and systematic review

Jeffrey Scott, Ritva Vyas, Jessica Galvin, Erica Gotow, Lori Fiessinger, Adam T. Gerstenblith, Meg R. Gerstenblith

Research output: Contribution to journalArticle

Abstract

Importance: Primary bilateral uveal melanoma (UM) is a rare and incompletely described entity. It is not known how these patients compare to those with unilateral UM. Background: We sought to comprehensively characterize and compare patients with primary bilateral and unilateral UM. Design: Retrospective, population-based and systematic review. Participants: Patients with bilateral (n = 52) and unilateral UM (n = 8915). Methods: We analysed cases of primary bilateral UM from three data sources: (i) the University Hospitals Cleveland Medical Center pathology database from 1996 to 2016 (n = 1); (ii) the Surveillance, Epidemiology and End-Results (SEER)-18 database from 1973 to 2013 (n = 5) and (iii) a systematic review of the English language literature (n = 46). Cases of unilateral UM were obtained from the SEER-18 database from 1973 to 2013 for comparison (n = 8915). Main Outcome Measures: Demographics, clinicopathological characteristics, treatments and survival. Results: There were no differences in sex, race, mean age at diagnosis, site of uveal involvement, metastases at diagnosis, or treatment among patients with bilateral as compared to unilateral UM. Additionally, there were no clinicopathological differences between the two UMs in each patient with bilateral disease. Overall survival did not differ between unilateral and bilateral UM patients, or between bilateral UM patients who presented with, or subsequently developed, bilateral disease. Conclusions and Relevance: Bilateral and unilateral UM patients share similar demographics, clinicopathological characteristics, treatments and prognoses. Moreover, the development of bilateral disease does not portend a poorer prognosis and patients should be treated similarly to those with unilateral disease.

Original languageEnglish (US)
Pages (from-to)502-510
Number of pages9
JournalClinical and Experimental Ophthalmology
Volume46
Issue number5
DOIs
StatePublished - Jul 1 2018
Externally publishedYes

Fingerprint

Population
Databases
Epidemiology
Demography
Uveal melanoma
Survival
Information Storage and Retrieval
Sex Characteristics
Language
Therapeutics
Outcome Assessment (Health Care)
Pathology
Neoplasm Metastasis

Keywords

  • Surveillance, Epidemiology and End-Results 18 database
  • systematic review
  • Uveal melanoma

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Scott, J., Vyas, R., Galvin, J., Gotow, E., Fiessinger, L., Gerstenblith, A. T., & Gerstenblith, M. R. (2018). Primary bilateral uveal melanoma: a population-based study and systematic review. Clinical and Experimental Ophthalmology, 46(5), 502-510. https://doi.org/10.1111/ceo.13129

Primary bilateral uveal melanoma : a population-based study and systematic review. / Scott, Jeffrey; Vyas, Ritva; Galvin, Jessica; Gotow, Erica; Fiessinger, Lori; Gerstenblith, Adam T.; Gerstenblith, Meg R.

In: Clinical and Experimental Ophthalmology, Vol. 46, No. 5, 01.07.2018, p. 502-510.

Research output: Contribution to journalArticle

Scott, J, Vyas, R, Galvin, J, Gotow, E, Fiessinger, L, Gerstenblith, AT & Gerstenblith, MR 2018, 'Primary bilateral uveal melanoma: a population-based study and systematic review', Clinical and Experimental Ophthalmology, vol. 46, no. 5, pp. 502-510. https://doi.org/10.1111/ceo.13129
Scott, Jeffrey ; Vyas, Ritva ; Galvin, Jessica ; Gotow, Erica ; Fiessinger, Lori ; Gerstenblith, Adam T. ; Gerstenblith, Meg R. / Primary bilateral uveal melanoma : a population-based study and systematic review. In: Clinical and Experimental Ophthalmology. 2018 ; Vol. 46, No. 5. pp. 502-510.
@article{d9d5127627af4ab29fcd65a9b0a0317a,
title = "Primary bilateral uveal melanoma: a population-based study and systematic review",
abstract = "Importance: Primary bilateral uveal melanoma (UM) is a rare and incompletely described entity. It is not known how these patients compare to those with unilateral UM. Background: We sought to comprehensively characterize and compare patients with primary bilateral and unilateral UM. Design: Retrospective, population-based and systematic review. Participants: Patients with bilateral (n = 52) and unilateral UM (n = 8915). Methods: We analysed cases of primary bilateral UM from three data sources: (i) the University Hospitals Cleveland Medical Center pathology database from 1996 to 2016 (n = 1); (ii) the Surveillance, Epidemiology and End-Results (SEER)-18 database from 1973 to 2013 (n = 5) and (iii) a systematic review of the English language literature (n = 46). Cases of unilateral UM were obtained from the SEER-18 database from 1973 to 2013 for comparison (n = 8915). Main Outcome Measures: Demographics, clinicopathological characteristics, treatments and survival. Results: There were no differences in sex, race, mean age at diagnosis, site of uveal involvement, metastases at diagnosis, or treatment among patients with bilateral as compared to unilateral UM. Additionally, there were no clinicopathological differences between the two UMs in each patient with bilateral disease. Overall survival did not differ between unilateral and bilateral UM patients, or between bilateral UM patients who presented with, or subsequently developed, bilateral disease. Conclusions and Relevance: Bilateral and unilateral UM patients share similar demographics, clinicopathological characteristics, treatments and prognoses. Moreover, the development of bilateral disease does not portend a poorer prognosis and patients should be treated similarly to those with unilateral disease.",
keywords = "Surveillance, Epidemiology and End-Results 18 database, systematic review, Uveal melanoma",
author = "Jeffrey Scott and Ritva Vyas and Jessica Galvin and Erica Gotow and Lori Fiessinger and Gerstenblith, {Adam T.} and Gerstenblith, {Meg R.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1111/ceo.13129",
language = "English (US)",
volume = "46",
pages = "502--510",
journal = "Clinical and Experimental Ophthalmology",
issn = "1442-6404",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Primary bilateral uveal melanoma

T2 - a population-based study and systematic review

AU - Scott, Jeffrey

AU - Vyas, Ritva

AU - Galvin, Jessica

AU - Gotow, Erica

AU - Fiessinger, Lori

AU - Gerstenblith, Adam T.

AU - Gerstenblith, Meg R.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Importance: Primary bilateral uveal melanoma (UM) is a rare and incompletely described entity. It is not known how these patients compare to those with unilateral UM. Background: We sought to comprehensively characterize and compare patients with primary bilateral and unilateral UM. Design: Retrospective, population-based and systematic review. Participants: Patients with bilateral (n = 52) and unilateral UM (n = 8915). Methods: We analysed cases of primary bilateral UM from three data sources: (i) the University Hospitals Cleveland Medical Center pathology database from 1996 to 2016 (n = 1); (ii) the Surveillance, Epidemiology and End-Results (SEER)-18 database from 1973 to 2013 (n = 5) and (iii) a systematic review of the English language literature (n = 46). Cases of unilateral UM were obtained from the SEER-18 database from 1973 to 2013 for comparison (n = 8915). Main Outcome Measures: Demographics, clinicopathological characteristics, treatments and survival. Results: There were no differences in sex, race, mean age at diagnosis, site of uveal involvement, metastases at diagnosis, or treatment among patients with bilateral as compared to unilateral UM. Additionally, there were no clinicopathological differences between the two UMs in each patient with bilateral disease. Overall survival did not differ between unilateral and bilateral UM patients, or between bilateral UM patients who presented with, or subsequently developed, bilateral disease. Conclusions and Relevance: Bilateral and unilateral UM patients share similar demographics, clinicopathological characteristics, treatments and prognoses. Moreover, the development of bilateral disease does not portend a poorer prognosis and patients should be treated similarly to those with unilateral disease.

AB - Importance: Primary bilateral uveal melanoma (UM) is a rare and incompletely described entity. It is not known how these patients compare to those with unilateral UM. Background: We sought to comprehensively characterize and compare patients with primary bilateral and unilateral UM. Design: Retrospective, population-based and systematic review. Participants: Patients with bilateral (n = 52) and unilateral UM (n = 8915). Methods: We analysed cases of primary bilateral UM from three data sources: (i) the University Hospitals Cleveland Medical Center pathology database from 1996 to 2016 (n = 1); (ii) the Surveillance, Epidemiology and End-Results (SEER)-18 database from 1973 to 2013 (n = 5) and (iii) a systematic review of the English language literature (n = 46). Cases of unilateral UM were obtained from the SEER-18 database from 1973 to 2013 for comparison (n = 8915). Main Outcome Measures: Demographics, clinicopathological characteristics, treatments and survival. Results: There were no differences in sex, race, mean age at diagnosis, site of uveal involvement, metastases at diagnosis, or treatment among patients with bilateral as compared to unilateral UM. Additionally, there were no clinicopathological differences between the two UMs in each patient with bilateral disease. Overall survival did not differ between unilateral and bilateral UM patients, or between bilateral UM patients who presented with, or subsequently developed, bilateral disease. Conclusions and Relevance: Bilateral and unilateral UM patients share similar demographics, clinicopathological characteristics, treatments and prognoses. Moreover, the development of bilateral disease does not portend a poorer prognosis and patients should be treated similarly to those with unilateral disease.

KW - Surveillance, Epidemiology and End-Results 18 database

KW - systematic review

KW - Uveal melanoma

UR - http://www.scopus.com/inward/record.url?scp=85040256782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040256782&partnerID=8YFLogxK

U2 - 10.1111/ceo.13129

DO - 10.1111/ceo.13129

M3 - Article

C2 - 29219254

AN - SCOPUS:85040256782

VL - 46

SP - 502

EP - 510

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

SN - 1442-6404

IS - 5

ER -